FDA Inspection 1115845 — Ingenus Pharmaceuticals GmbH

Ingenus Pharmaceuticals GmbH — FEI 3005403232

The FDA completed an inspection of Ingenus Pharmaceuticals GmbH on Dec 3, 2019 in Barbengo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 3, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barbengo (Switzerland)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.